MORGAN STANLEY - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,093,199
+43.7%
136,821
+56.5%
0.00%
Q2 2023$760,588
+189.6%
87,424
-2.1%
0.00%
Q1 2023$262,658
+206.5%
89,339
+264.9%
0.00%
Q4 2022$85,698
+8.5%
24,485
+143.8%
0.00%
Q3 2022$79,000
-13.2%
10,043
-14.2%
0.00%
Q2 2022$91,000
-19.5%
11,711
+26.6%
0.00%
Q1 2022$113,000
-53.5%
9,248
-53.5%
0.00%
Q4 2021$243,000
+279.7%
19,893
+221.9%
0.00%
Q3 2021$64,000
-57.3%
6,180
-63.1%
0.00%
Q2 2021$150,000
+383.9%
16,744
+456.3%
0.00%
Q1 2021$31,000
+138.5%
3,010
+49.8%
0.00%
Q4 2020$13,0002,0100.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders